SRZN.US Surrozen Inc

Healthcare Biotechnology USA Stocks
32.32 USD
Close of Nov 17, 2026
12.79 37.83
Market cap
USD 616M
P/E
-
P/B
2.50x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is SRZN.US undervalued?

Graham number

The Graham number of Surrozen Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Surrozen Inc fundamental analysis

No fundamental analysis for Surrozen Inc yet.

Surrozen Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Surrozen Inc

Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the eye, intestine, liver, lung, retina, kidney, cochlea, cornea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor …

Full company profile